SCHEMBL27780397

SCHEMBL27780397

CC(C)n1cnc2c(N(C)c3ccncc3)nc(F)nc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ MDM2 Q00987 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ HTT P42858 1/20 0.44
▸ CDK2 P24941 14/20 0.44
▸ CDK5 Q00535 10/20 0.44
▸ CCNA2 P20248 10/20 0.44
▸ CCNA1 P78396 10/20 0.44
▸ DYRK1A Q13627 9/20 0.44
▸ CDK5R1 Q15078 9/20 0.44
▸ CDK1 P06493 4/20 0.40
▸ CCNE1 P24864 3/20 0.39
▸ CCNB1 P14635 2/20 0.39
▸ CCNE2 O96020 1/20 0.37
▸ MAPK13 O15264 1/20 0.37
▸ MAPK12 P53778 1/20 0.37
▸ MAPK11 Q15759 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27553389 0.86 MAPK1 (0.47) NPSR1MAPK1MAPTMDM2TDP1
SCHEMBL7525338 0.80 HTT (0.67) NPSR1MAPK1MAPTMDM2TDP1
SCHEMBL19112099 0.78 NPSR1 (0.47) NPSR1MAPK1MAPTMDM2TDP1
SCHEMBL4497263 0.73 CDK2 (0.73) CDK2CDK5CCNA2CCNA1DYRK1A
SCHEMBL3298664 0.72 CDK2 (0.44) MAPK1CDK2CDK5CCNA2CCNA1
SCHEMBL27573678 0.71 CDK2 (0.58) NPSR1MAPK1MAPTMDM2TDP1
SCHEMBL3298667 0.71 CDK1 (0.63) MAPK1MAPTTDP1CDK2CDK5
SCHEMBL1293109 0.69 CDK2 (0.49) MAPTTDP1CDK2CDK5CCNA2
SCHEMBL20656164 0.69 CDK2 (0.49) MAPK1MAPTTDP1CDK2CDK5
SCHEMBL14039518 0.69 CDK1 (0.71) MAPK1CDK2CDK5CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679434-B 2, 6, 9-substituted purine derivatives having anti proliferative properties CYCLACEL LTD 2013-09-25 — — CN disclosed
CN-101679434-A Has 2,6 of anti proliferative properties, the purine derivative that 9-replaces CYCLACEL LTD 2010-03-24 — — CN disclosed
Send feedback